260 related articles for article (PubMed ID: 30429459)
1. Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption.
Wang Y; Zhou Y; Zheng Z; Li J; Yan Y; Wu W
Cell Death Dis; 2018 Nov; 9(11):1134. PubMed ID: 30429459
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane metabolites inhibit migration and invasion via microtubule-mediated Claudins dysfunction or inhibition of autolysosome formation in human non-small cell lung cancer cells.
Zheng Z; Lin K; Hu Y; Zhou Y; Ding X; Wang Y; Wu W
Cell Death Dis; 2019 Mar; 10(4):259. PubMed ID: 30874545
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane-N-Acetyl-Cysteine inhibited autophagy leading to apoptosis via Hsp70-mediated microtubule disruption.
Hu Y; Zhou Y; Yang G; Wang Y; Zheng Z; Li J; Yan Y; Wu W
Cancer Lett; 2018 Sep; 431():85-95. PubMed ID: 29807114
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane metabolites cause apoptosis via microtubule disruption in cancer.
Zhou Y; Yang G; Tian H; Hu Y; Wu S; Geng Y; Lin K; Wu W
Endocr Relat Cancer; 2018 Mar; 25(3):255-268. PubMed ID: 29431641
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane-N-Acetyl-Cysteine Induces Autophagy Through Activation of ERK1/2 in U87MG and U373MG Cells.
Liu HJ; Wang L; Kang L; Du J; Li S; Cui HX
Cell Physiol Biochem; 2018; 51(2):528-542. PubMed ID: 30458452
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane downregulated fatty acid synthase and inhibited microtubule-mediated mitophagy leading to apoptosis.
Yan Y; Zhou Y; Li J; Zheng Z; Hu Y; Li L; Wu W
Cell Death Dis; 2021 Oct; 12(10):917. PubMed ID: 34620841
[TBL] [Abstract][Full Text] [Related]
7. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
[TBL] [Abstract][Full Text] [Related]
8. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
Gan PP; McCarroll JA; Po'uha ST; Kamath K; Jordan MA; Kavallaris M
Mol Cancer Ther; 2010 May; 9(5):1339-48. PubMed ID: 20442307
[TBL] [Abstract][Full Text] [Related]
9. [Down-regulated βIII-tubulin expression can reverse paclitaxel resistance in A549/taxol cells lines].
Zhuo Y; Guo Q
Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):581-7. PubMed ID: 25130963
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH
Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844
[TBL] [Abstract][Full Text] [Related]
11. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
Gan PP; Pasquier E; Kavallaris M
Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044
[TBL] [Abstract][Full Text] [Related]
12. Optimizing combination therapy in prostate cancer: mechanistic insights into the synergistic effects of Paclitaxel and Sulforaphane-induced apoptosis.
Habib TN; Altonsy MO; Ghanem SA; Salama MS; Hosny MA
BMC Mol Cell Biol; 2024 Mar; 25(1):5. PubMed ID: 38438917
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
[TBL] [Abstract][Full Text] [Related]
14. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
15. High levels of EGFR prevent sulforaphane-induced reactive oxygen species-mediated apoptosis in non-small-cell lung cancer cells.
Wang TH; Chen CC; Huang KY; Shih YM; Chen CY
Phytomedicine; 2019 Nov; 64():152926. PubMed ID: 31454652
[TBL] [Abstract][Full Text] [Related]
16. The effect of sulforaphane on the cell cycle, apoptosis and expression of cyclin D1 and p21 in the A549 non-small cell lung cancer cell line.
Żuryń A; Litwiniec A; Safiejko-Mroczka B; Klimaszewska-Wiśniewska A; Gagat M; Krajewski A; Gackowska L; Grzanka D
Int J Oncol; 2016 Jun; 48(6):2521-33. PubMed ID: 27035641
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
[TBL] [Abstract][Full Text] [Related]
18. Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression.
Mao K; Liu F; Liu X; Khuri FR; Marcus AI; Li M; Zhou W
Lung Cancer; 2015 May; 88(2):131-8. PubMed ID: 25769882
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of covalent modifications of tubulins by isothiocyanates.
Xiao Z; Mi L; Chung FL; Veenstra TD
J Nutr; 2012 Jul; 142(7):1377S-81S. PubMed ID: 22649267
[TBL] [Abstract][Full Text] [Related]
20. Low dose HSP90 inhibition with AUY922 blunts rapid evolution of metastatic and drug resistant phenotypes induced by TGF-β and paclitaxel in A549 cells.
Bacon NA; Larre I; Lawag AA; Merritt C; Smith M; Rosolen M; Sollars VE
Biomed Pharmacother; 2020 Sep; 129():110434. PubMed ID: 32768937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
